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INTRODUCTION
Seizures are the most common manifestation of neurological disorder in the 
neonatal period and may be the only clinical indication of neurological dysfunction in 
this age group. Neonatal seizures is a clinical emergency which represent an age-
specific seizure disorder, which is usually considered to be in a separate category 
from epilepsy. Neonatal seizures also have many other characteristics that are quite 
different from seizures in children and adults. Neonatal seizures are rarely 
idiopathic(10,11,32,35)  and are the single most major predictors of adverse neurological 
outcome.
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DEFINITION
The International League against Epilepsy classification adapted by 
WHO still considers neonatal seizures within an UNCLASSIFIED 
CATEGORY (commission 1981)(50).  Neonatal seizures(32,35,36) is defined 
as paroxysmal alterations in neurological function. This definition allow 
the inclusion of clinical seizures associated with EEG abnormality as well 
as paroxysmal clinical activities that involves motor, behavioural or 
autonomic functions that are not associated with EEG alterations.
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BURDEN OF ILLNESS 
Newborn babies are vulnerable to epileptogenic activity, thus have 
a high incidence of seizures(10,11,32,35,40,64) 1-2/1000 in term infants and up to 
60/1000 in premature infants. Neonatal seizures are among the most 
common causes of morbidity and mortality among neonates. 
The reported incidence of neonatal seizures varies widely across 
studies, that is primarily the result of inconsistent diagnostic criteria, 
subtle manifestation and their potential confusion with non-epileptic 
neonatal behaviours. Regardless of precise incidence, it is clear that 
seizures are more common in neonatal period and the tendency towards 
recurrent seizures and status epilepticus is far greater in newborn period.
PATHOPHYSIOLOGY (10,11,32,35)
The neurons within the CNS undergo depolarization as a result of 
inward migration of sodium  and repolarization occurs via efflux of 
potassium. A seizure occurs when there is excessive depolarization, 
resulting in excessive synchronous electrical discharge. Volpe(2001)(3) 
proposed the following four possible reasons for excessive 
depolarization.
(1) Failure of the sodium-potassium pump because of a disturbance in 
energy production
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(2) A relative excess of excitatory versus inhibitory neurotransmitter
(3) A relative deficiency of inhibitory versus excitatory 
neurotransmitter.
(4) Alteration in the neuronal membrane, causing inhibition of sodium 
movement. 
However, the basic mechanisms of neonatal seizures are unknown.
The decreased seizure threshold in the newborn reflects the 
developmental events active in the immature brain. In essence, the 
newborn brain has a transient over development of excitatory systems 
compared to inhibitory systems. For example, the immature brain has a 
transient overexpression in the density of excitatory amino acid 
(primarily glutamate) receptors and a relative paucity of glutamate 
reuptake transporters. Together these features translate into more 
prolonged and intense contact of glutamate with postsynaptic receptors. 
Furthermore, these immature glutamate receptors are far more permissive 
of cationic influx, facilitating membrane depolarization and seizure 
activation, in contrast, inhibitory gamma-aminobutyric acid (GABA) ion 
channels are relatively underexpressed in the immature brain.  In fact, in 
certain areas of the developing brain these immature GABA may be 
depolarizing rather than hyperpolarizing. In addition to these cellular 
factors, differential development of neural systems may enhance the 
excitatory state of the immature brain and predispose to seizures.
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ETIOLOGY
A specific etiology for neonatal seizures can usually be identified 
in the majority of cases. In contrast to children who often develop 
idiopathic epilepsy without identified cause, it is relatively rare for an 
otherwise healthy baby to have epileptic seizures. In this respect, 
neonates more closely resemble older adults in that most new onset 
seizures among the elderly are also symptomatic,  such as from a stroke, 
brain tumour or neurodegenerative disease. Infact because the neonatal 
nervous system has a relatively limited repertoire of behavior and 
symptoms,  seizures are often the only neurological manifestation of a 
serious underlying neurological or systemic disease. Therefore if a 
neonate develops seizures and the etiology is not readily apparent an 
extensive diagnostic work-up is often warranted.
There are numerous causes of neonatal seizures, but relatively most 
common causes are as follows:
(1) CEREBRAL HYPOXIA AND ISCHAEMIA
It can be global or focal ischaemic injury
(a)  Global – Perinatal hypoxia: It  is  a  leading  cause  of  neonatal 
seizures(2) which occurs in antenatal, intrapartum or neonatal period and 
account for 25-40% of neonatal seizures.  Most post-asphyxial seizures 
occur within first 24hours after the insult, 50% or more occurring within 
twelve hours.  The seizure onset  is  likely to be influenced by severity, 
duration and onset of intra-uterine asphyxia insult. It is likely that more 
11
severe insults are followed by earlier onset seizure, but this is not firmly 
established. In premature infants seizure are of the generalized tonic type 
whereas in full term, multi-focal clonic type is common. Accompanying 
subtle seizures are usually present in both types.
(b)  Focal ischaemic injury:  It can be caused by arterial stroke or 
venous thrombosis. Seizures are the most common presentation of stroke 
in  neonatal  period  and  stroke  is  the  second  most  common  cause  of 
neonatal  seizures accounting 15-20%. Arterial  strokes most  commonly 
involves left middle cerebral artery and thus right clonic seizures are most 
common.  Cerebral  venous  thrombosis  usually  occurs  in  large  dural 
sinuses  particularly  in  the  posterior  aspects  of  superior  saggital  sinus 
which usually presents as subtle seizures and lethargy. Mental status is 
relatively normal in arterial stroke whereas in venous thrombosis neonate 
is more encephalopathic.
(2) INTRACRANIAL HAEMARRHAGE
This is implicated in 10% of neonatal seizures and clinical features 
varies with gestational age. Term infants have sub-arachnoid hemorrhage 
in common and less often sub-dural hemorrhage. Sub-arachnoid 
hemorrhage usually results in focal or multifocal seizures from second 
day of life and have a good long-term outcome in 90% of cases. Sub-
dural hemorrhage usually presents with seizures on first day of life.
Post-hemarrhagic seizures in premature infants have different 
features and more ominous prognosis. These seizures are usually 
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associated with severe intra-ventricular hemorrhage and peri-ventricular 
hemorrhagic infarct and usually present within first three days. The 
newborn is usually sick and have poor prognosis
(3) CNS INFECTION
Seizure can be caused by meningitis or encephalitis from variety of 
bacterial or viral agents or other organisms like cytomegalovirus and 
toxoplasmosis. It can also be caused due to cerebral abscess. The 
mechanism of seizures in this may be through direct cerebritis or vaso-
occlusive injury with secondary seizures and usually develop in later part 
of first week or later.
(4) METABOLIC DISTURBANCE
It can be transient and rapidly correctable or persistent inherited 
causes. Transient causes include hypoglycemia, hypocalcemia, 
hypomagnesemia, hyponatremia and hypernatremia. It usually occurs in 
conjunction with other potentially epileptogenic conditions such as 
perinatal asphyxia. Most of the persistent inherited conditions are due to 
permanent enzyme defects and are largely incurable. However, their 
recognition is important for two reasons.
 Some metabolic disturbances have transient forms that resolve over 
time as some forms of non-ketotic hyperglycemia.
 Some are treatable as pyridoxine dependent seizures.
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(5) CEREBRAL DYSGENESIS
Conditions most commonly associated with neonatal seizures are:
 Disorders of neuronal migration like heterotropias, lissencephaly, 
etc.
 Disorders of neuronal organization like polymicrogyria
These ectopic or disorganized collection of neurons are abnormally 
prone to hyperexcitability and burst of discharges leading to seizures.
(6) EPILEPTIC SYNDROMES IN NEONATES
There are two benign and three malignant epileptic syndromes 
presenting with seizures in neonate:
 Benign familial neonatal seizures and benign idiopathic seizures.
 Neonatal myoclonic encephalopathy, Ohtahara syndrome and 
Migrating partial seizures of infancy (Coppola syndrome)
These malignant encephalopathies are usually associated with poor 
prognosis.
(7) OTHERS 
The drugs used in mother can cause drug withdrawal and drug 
toxicity resulting in seizures in infants. Inadvertent injection of local 
anesthetics into the fetus at the time of delivery may cause generalized 
seizures. Kernicterus and AICARDI syndrome are also rare causes.
The time of onset helps in determining the likely etiology(27)
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AGE OF 
ONSET
LIKELY ETIOLOGY
<24 hrs HIE, severe birth trauma, congenital anomalies of CNS, pyridoxine dependency, hypoglycemia, drugs.
24-48hrs All the above + milder birth trauma, hypocalcemia, hypomagnesemia, infarcts, some IEM.
48-72hrs All the above + dyselectrolytemia, sepsis, other encephalopathies.  
72hrs-1wk All the above + benign neonatal seizures
>1wk
Late hypocalcemia, sepsis, progressive 
hydrocephalus, cerebral dysgenesis, epileptic 
syndromes, herpes encephalitis, some IEM.
 CLINICAL FEATURES
It is important to understand that seizures in the neonate are 
different from those in older children. The difference is perhaps due to 
the neuroanatomic and neurophysiologic developmental status of the 
neonate. In the neonatal brain glial proliferation, neuronal migration, 
establishment of axonal and dendritic contacts and myelin deposition are 
incomplete. The relatively underdeveloped organization of cortex and 
undermyelination of axons are likely to cause the disorganized convulsive 
activity and lack of orderly seizure propagation in neonate. For same 
reasons, primary generalized seizures are very rare in neonate ( exception 
is Benign familial neonatal seizures).
Clinically seizures are categorized broadly into four groups – subtle, clonic, 
tonic and myoclonic. In many cases more than one type of seizures occurs in a 
neonate over time.
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(1) SUBTLE SEIZURES:(13)  It is most common and accounts for half 
of all seizures in full and premature neonates. Subtle seizures are rarely 
isolated and will almost always have other seizure types as well. It 
includes broad spectrum of behavioral phenomenon occurring in isolation 
or in combination.
 Ocular:  Most common and it includes tonic eye deviation, 
     roving nystagmoid  eye movement and sudden 
     sustained eye opening with apparent visual fixation.
 Oro-bucco-lingual: chewing, sucking and lip smacking. These are 
often associated with drooling.
 Progressive movements: pedaling, boxing, rowing and swimming.
 Autonomic phenomenon: sudden change in skin colour, 
tachycardia and apnoea 
Most subtle seizures are not associated with EEG seizures. Based on their 
inconsistent association with EEG as well as their poor response to conventional anti-
convulsant, many consider these seizures to be non-epileptic “brainstem release 
phenomenon”.
(2) CLONIC SEIZURES:  It is most common in full term infants 
and are commonly associated with EEG seizures. It is stereotypic and 
repetitive biphasic movements with a fast contraction phase and slow 
relaxation phase involving muscle groups of limbs, face and trunk. It can 
be unifocal, multifocal or generalized. Common causes are neonatal 
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stroke, focal traumatic contusions, sub-arachnoid hemorrhage or 
metabolic disturbances.
(3) TONIC SEIZURES:  These are most common in premature 
infants. It is characterized by sustained period of muscle contractions 
without repetitive features. It can be focal or generalized. It is often 
associated with motor automatism or clonic seizures and infants are 
obtunded or lethargic between seizures. It is usually not associated with 
EEG seizures. The background EEG tends to have multifocal generalized 
voltage depression and undifferentiated frequencies. Diffuse neurological 
dysfunction and major intra-ventricular hemorrhage are major causes and 
prognosis is usually very poor.(21)
(4) MYOCLONIC SEIZURES: It occurs both in full term and 
premature infant. It is characterized by lightning fast contractions and 
non-rhythmic character. It can be focal, multifocal or generalized. 
Myoclonic seizures are associated with diffuse and usually serious brain 
dysfunction like perinatal asphyxia, IEM, cerebral dysgenesis and major 
brain trauma. The electroclinical association of these seizures is variable.
SEIZURE MIMICS:(29)
In newborn it may be difficult to distinguish between normal 
immature behavior like non-nutritive sucking and abnormal but non-
epileptic behavior like jitteriness from true epileptic manifestations.
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Non-epileptic phenomena can be distinguished clinically by:
 Can be provoked by stimulation
 Can be suppressed by gentle restraint
 Not accompanied by abnormal eye movements
 Not associated with autonomic changes (Tachycardia, increase BP, 
etc)
     Have rhythmic oscillatory quality. Do not have jerky fast and slow 
components. 
     No EEG abnormality.
INVESTIGATIONS
 It is mandatory to do blood glucose, serum calcium, serum 
magnesium, blood urea, serum electrolytes and blood gas levels. 
They may reveal the abnormality causing the seizures.
 CSF analysis is essential because of consequence of delayed 
treatment or non-treatment are grave. Septic work up is mandatory 
including peripheral smear, blood and urine culture and CRP.
 Ultrasonography of head is available bedside diagnosis and is good 
to rule out intra-ventricular hemorrhage and peri-ventricular 
hemorrhage. It has more value in prognostication. In a study 
conducted by Levene et al, 20% of neonate with seizures were 
detected to have intracranial hemorrhage or infarction in middle 
cerebral artery by real time ultrasonography. So routine imaging 
technique was advised in all neonates with seizures.
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 EEG(38) is indicated in all cases of seizures which is recurrent, 
resistant and those associated with abnormal neurological findings 
and where no definite etiology is forthcoming. By definition EEG 
seizures is a repetitive series of electrical discharges that evolves in 
frequency, amplitude and topographic field. The threshold criterion 
for diagnosis of EEG seizures has been set at 10secs or more of 
repetitive electrographic discharges. Gestational age has an 
important influence on EEG expression of seizures in neonate. 
EEG seizures are rare in babies with gestation age less than 34wks. 
Unlike the interictal EEG in older patients with seizures, the 
neonate EEG lacks interictal epileptiform pattern that reliably 
predict the risk for subsequent seizure. In fact, the development of 
EEG seizures in newborn has been described as an all or none 
phenomenon.  
SUSPECTED SEIZURES
EEG Recorded ( Preferably Not Later Than 24hrs )
 
            Abnormal           Normal
         Watch For Seizure Recurrence
Start Antiepileptic
Video EEG                               Yes             No
Monitoring
For 24-48hrs             Repeat EEG       Follow-Up
                                        Abnormal    Normal
  
                        Interictal EEG
                               
            Abnormal        Normal
REPEAT EEG AFTER ONE WEEK
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(PROGNOSTIC VALUE)
 CT/MRI is helpful in looking for evidence of infarction, 
hemorrhage, calcification and cerebral malformation. CT is good 
for hemorrhages and calcification whereas MRI provides better 
resolution of anatomy and details of function and perfusion with 
diffusion weighted MRI, MRS and MRA.
 Others: If suspected to have chromosomal abnormalities, 
karyotyping can be done. Urine examination for reducing 
substances and metabolic screening can be done. TORCH 
screening can be done. With family history of neonatal seizures or 
fetal loss, history and examination suggestive of IEM, blood 
ammonia, plasma and urine aminoacidogram, serum and CSF 
lactate:pyruvate ratio, blood and urine pH can be done.                 
MANAGEMENT
As a general rule, seizures in neonate are less responsive to 
conventional anticonvulsants than are seizures in older patients. A 
number of potentially deleterious effects on the systemic and cerebral 
systems support the treatment of neonatal seizures.(28) First, seizures may 
cause significant hemodynamic and respiratory disturbances, which in the 
sick newborn, may complicate management and potentially extend brain 
injury. Seizures disrupt cerebral pressure autoregulation and cause wide 
fluctuations in blood pressure, a combination with potentially serious 
consequences for the immature brain. Second, massive amounts of 
cerebral energy are consumed during the repeated neuronal 
depolarization-repolarization associated with seizures. Neonatal seizures 
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cause a rapid fall in cerebral glucose and rise in brain lactate, even with 
normal or elevated bold glucose levels. In the insulted brain, such energy 
depletion may seriously compromise recovery. Third, seizures release 
large amounts of glutamate, and in conditions of cerebral energy failure, 
seizures inhibit the reuptake of glutamate. Together these mechanisms 
result in the accumulation of extracellular glutamate to toxic levels that 
are potentially lethal to postsynaptic neurons and immature 
oligodendrocytes. Seizures may also disrupt protein and lipid metabolism 
of immature neurons and activate genes that stimulate axonal growth and 
new synapse formation. These sublethal insults may result in aberrant 
neuronal pathways and a long-term reduction in seizure threshold. 
Together, these mechanisms likely contribute to the epilepsy, motor and 
cognitive impairment seen in some survivors of neonatal seizures. 
So, once a seizure is appreciated clinically in a neonate, it is taken 
as an emergency and warrants the following actions.
 Stabilisation of the neonate and treatment of the seizure.       
 Detection and treatment of underlying cause.
 Long term planning and prognostication.
The repertoire of drugs used for neonatal seizures is relatively limited for 
several reasons. First, few drugs have been formally tested in the neonatal population. 
Second, oral preparations often cannot be used in neonates. Finally, the complicated 
metabolism and pharmacokinetics of neonates makes use of some drugs difficult.
Unresolved issues in treatment of seizures are
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 Optimal maintenance doses of anticonvulsants.
 Importance of eliminating electrographic seizures.
 Optimal duration of anticonvulsant therapy.
 Whether anti-epileptic drugs or seizures adversely affect immature 
brain.
After recovery from neonatal seizures, the duration of treatment 
with anti-epileptic drugs beyond the neonatal period varies, depending 
most on the predicted prognosis for seizure recurrence. It mainly depends 
on etiology, neurological status and EEG. Early withdrawal of 
antiepileptics(58) is beneficial for the neurodevelopment outcome. Long 
term anti-convulsant may be considered in neonate with recurrent 
seizures with persistent neurological abnormality, EEG abnormality or 
family history of seizures.
PROGNOSIS
As a result of improved obstetric management and modern 
neonatal intensive care, the outcome of infants with seizures has 
improved with overall prognosis for survival around 85%. Unfortunately, 
the prognosis for long term neurodevelopmental outcome remains largely 
unchangeable. There are numerous studies done on outcome and 
prognosis of neonatal seizures. Most of them showed 10-50% mortality 
mostly during neonatal period and it has been decreasing 
nowadays(Volpe, 1995)(12) . 50% of them were found to have long term 
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neurological complications like epilepsy, mental retardation, cerebral 
palsy (25-35% - Neurological sequelae and 17% - seizures). 
The prognosis depends on type of clinical seizure, etiology, 
associated problems, effect of intervention, EEG changes and severity of 
insult.
*ETIOLOGY: Hypocalcemia(20) and primary sub-arachnoid 
hemorrhage has best prognosis while cerebral dysgenesis(1,2,6) have worst 
prognosis. Hypoglycemia, infection and infarcts have a poor prognosis if 
extensive and prolonged duration. The outcome of intracranial 
hemorrhage depends on degree of parenchymal injury. If extensive 
diagnostic evaluation fails to identify an etiology, the outcome is likely to 
be favourable.
*Among seizure types,(21)  focal clonic have invariably benign 
course while persistent tonic seizures and myoclonic seizures have poor 
outcome. Refractory seizures and seizures lasting for >30mts have poor 
prognosis.
 *Infants with gestation age <32wks have high mortality rate of 
80% and significantly higher risk of adverse neurological outcome among 
survivors.
 *A better outcome may be expected when clinical and EEG 
seizures are consistently correlated whereas electrically silent clinical 
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seizures or clinically silent EEG seizures have worst prognosis. Interictal 
burst suppression pattern, isoelectric EEG, multifocal abnormal 
discharges in EEG(18,22,25) predict poor neurological outcome in >80% of 
cases. Unifocal diphasic spike and sharp wave pattern has good 
prognosis. Myoclonic seizures with spike burst pattern have worst 
prognosis.
 * Neonatal neurological examination is also a good predictor of 
outcome in patients with neonatal seizures. With normal neurological 
examination being associated with good prognosis and abnormal predicts 
poor outcome.
* Response to first antiepileptic(41) is the most powerful predictor 
for good prognosis.
* Shorter the course of antiepileptic drugs, better is the outcome.(58)
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REVIEW OF LITERATURE
Assessment of development status and long term outcome of child 
is gaining more importance especially of  the at risk neonate.  In this era 
of  advanced health infrastructure and era of preventive medicine, many 
studies has been conducted to know the long term outcome of neonatal 
seizures.
IYPE et al,(1)  from a medical college in Kerala, undertook a 
follow-up study in neonate with seizures with objective to determine the 
sequelae of neonatal seizures in a cohort of newborns recruited over a six 
month period. It was a prospective hospital based study performed in 
NICU of a tertiary care hospital. 135 babies were recruited of  whom 10 
died and 25 lost to follow-up, rest of  the cases were followed up over 
four months.  While analysing the results, 68%  had normal outcome, 
32%  had abnormal neurological outcome and 7% had post natal epilepsy. 
Hypocalcemia was significantly associated  with mortality [ OR: 21.9, 
95% CI: 1.2-391.2] and no risk factor could be identified for postnatal 
epilepsy.  Presence of spike waves in EEG was significantly related to 
abnormal neurological outcome {OR: 3.5, CI: 1.2-10.8}. Thus the 
conclusion of the study was that majority of  neonates with seizures have 
normal outcome with no developmental delay or neurological deficit and 
predominantly spike waves in EEG is predictor of abnormal neurological 
outcome.
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TEKGUL et al,(2) conducted a study in children hospital in Boston, 
with 89 infants with clinical neonatal seizures. All these infants 
underwent neurological examination, EEG, neuroimaging and extensive 
diagnosis tests in neonatal period. After discharge, all infants underwent 
regular  neurological evaluation at 12-18months and formal 
neurodevelopmental testing and prognostic value of seizure etiology, 
neurologic examination, EEG and neuroimaging were tested. In 77% of 
cases etiology was identified, Global and  focal cerebral hypoxia-
ischaemia and intracranial hemarrhage were most common.  Mortality 
was around 7% and 28% had poor neurological outcome.
Association between seizure etiology and outcome was strong, 
with cerebral dysgenesis  and global hypoxia-ischaemia  being associated 
with poor outcome. Normal neonatal period or early infancy neurological 
examination was associated with uniformly favourable outcome 
at 12-18months. Abnormal neurological examination in prediciting poor 
outcome lack specificity. Normal or mildly abnormal EEG had 
favourable outcome, particularly if neuroimaging was normal. Moderate 
or severely abnormal EEG and multifocal diffuse cortical or primary deep 
grey matter lesions had worse outcome. Thus it was concluded that the 
mortality associated with neonatal seizures has declined although  long 
term neurodevelopment morbidity remains unchanged. The powerful 
prognostic factors remained to be seizure etiology and background EEG. 
Diagnostic advancement have changed the etiological profile and 
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improved the accuracy of  outcome prediction, however global cerebral 
hypoxia-ischaemia  remains the most common etiology and is responsible 
for majority of infants with poor long term outcome.
GABRIEL M. RONEN et al,(6) in a population based study 
conducted in a health centre in Canada, assessed long term prognosis in 
children with neonatal seizures. The aim of the study was to examine the 
outcome and explore for prognostic markers in a cohort  <10yrs 
following neonatal seizures. The study was conducted between 
1990-1995  and children were followed up by specialised provincial 
health services. Follow-up data were collected on epilepsy, physical and 
cognitive impairment and other health issues. The data was available for 
82 infants among  90 registered. Prognosis was better for term than 
preterm (p=0.003). Among the term infants, 45% had normal outcome 
while 16% died and 39% had impairment. Among the preterm, only 12% 
had normal outcome, 42% died and 46%  had impairment. Of  the 
survivors, 27% had epilepsy, 25%  had cerebral palsy, 20% had mental 
retardation and learning disorder was present in 27% of them. Sarnat 
stage-III or equivalent severe encephalopathy, cerebral dysgenesis, 
complicated IVH, infection in preterm, abnormality in EEG and the need 
for multiple drugs were the variables associated with poor prognosis. 
Pure clonic seizures with focal involvement in term infants suggested 
favourable outcome whereas generalised myoclonic seizures in preterm 
was associated with increased mortality. It was concluded that poor 
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prognosis for preterm with seizures is reflected in high rates of 
subsequent long term disability and mortality. The severity and timing of 
pathologic process continue to be the major determinant for outcome.
A CANADIAN(44)  population based outcome study of neonatal 
seizures with follow-up of >10yrs had 35% normal outcome and 34% 
postnatal epilepsy. Same cohort  at the end of decade had only 12% 
normal outcome and had 48% postnatal epilepsy. Term babies had 
uniformly better outcome and short follow-up was associated with good 
outcome. Normal EEG with interictal epileptic discharge had poor 
outcome. Mild motor and cognitive deficits were also reported. Abnormal 
background activity was more correlative than interictal discharges for 
poor outcome. Hypocalcemia had high mortality, however they were 
small in number. So analysis showed wide confidence interval and make 
interpretation difficult.
A study done at HARVARD MEDICAL SCHOOL, BOSTON(48) 
correlated prenatal and perinatal events with outcome of neonatal 
seizures. The study included 277 neonates and it was a prospective cohort 
study. The mortality rate among the neonates was 34.8%. Among 181 
survivors, 70% had normal outcome, cerebral palsy was present in 13% 
of the cases, 19% had mental retardation (IQ<70)  and 20% had epilepsy. 
Low apgar score at birth, the requirement of  resuscitation >5mts, low 
birth weight, early onset seizures and prolonged seizures were identified 
to be the prognostic factors.
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GHERPELLI  JL et al,(37) in a follow-up study done in a medical 
School in Brazil, looked for seizure recurrence in infants with neonatal 
convulsions.  It was a prospective cohort study for 11months. 23 infants 
were followed up and all had a neurological examination, EEG , cranial 
USG performed at follow-up. Anti-convulsant was discontinued, if 
follow-up EEG and neurological examination were normal.  Seven out of 
twenty three, ie, 30% had seizure recurrence. Abnormal EEG, 
neurological examination and Cranial ultrasonography were statistically 
correlated with seizure recurrence. They concluded  that infants with 
neonatal seizures can remain free of anticonvulsant medication provided 
they have normal neurological examination, EEG and cranial USG. 
ARTHUR L. ROSE et al,(60) conducted a study of clinical, pathological 
features in 137  full term babies with neonatal seizures with a follow-up 
of four years. The study was carried out in Neurology department, 
Children’s Hospital Medical Centre, Boston. They followed 144 full term 
babies above 2.5kg who had seizures during their neonatal period. Seven 
subjects were lost in follow-up, leaving a total of 137. Clinical types were 
classified by observation. No etiological clues was present in 25% of 
babies and 75% had probable etiology. EEG in neonate period is helpful 
in prognostication. 86% of  babies with normal EEG had normal 
development at end of 4yrs. Flat, periodic or multifocal EEG was 
associated with normal development only in 7% of babies. At the end of 
the study 50% had normal outcome, 30% had neurological deficit and 
20% died.
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JOSEPH J. VOLPE et al,(12) demonstrated in a study conducted in 
Washington  School of  Medicine, that certain clinical seizures in neonate 
are  not consistently accompanied by seizure activity in EEG. Subtle 
seizures, most of  the generalized tonic seizures and focal and multifocal 
myoclonic seizures are the seizures of that category. Myoclonic jerks 
were found to originate from several levels of nervous system like 
brainstem, spinal cord and cortex.  
OUTCOME IN VARIOUS STUDIES
Character 
&Outcome
Iype et al 
(n=135)
Canadian 
study 
(n=90)
Harvard 
study 
(n=277)
Gherpelli et 
al (n=23)
Follow-up 
duration
1yr 10yrs 7yrs 11mo
Mortality 7% 34.8%
     Recurrenc
e
7% 34% 20% 30%
Cerebral 
palsy
32% 13%
Normal 68% 35% 70%
          One of studies done in 1999,(46) in rats, demonstrates that  recurrent 
neonatal seizures result in changes of neuronal connectivity  and 
alterations in seizure susceptibility, learning and memory. Degree of 
impairment following 50 seizures was modest, demonstrating that the 
immature brain is remarkably resistant to seizure induced damage.
Immature brain is more prone to seizure due to imbalance of 
excitatory and inhibitory neurotransmitters. This was reported in the 
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article of neuroscience, January 2002.(47) It was also stated in that article 
that neonatal seizures are also associated with a number of activity 
dependent changes in brain development including altered synaptogenesis 
and decreased neurogenesis. Functional abnormalities following seizures 
with impairment of visual-spatial memory and decreased seizure 
threshold  were demonstrated. Thus the conclusion was that neonatal 
seizure was no more a benign event.
KELLAWAY AND MIZRAHI,(13) in their studies showed that 
subtle seizures are motor automatism which includes oral-buccal-lingual 
movements, ocular signs, limb and axial movements as swimming, 
stepping, pedalling and struggling movements of head and trunk. This 
was probably thought due to brainstem release phenomenon. They also 
said that clinical distinction of epileptic from non-epileptic activity at bed 
side can be made by sensitivity of movements or posturing to sensory 
stimulation, ability to suppress the movements by gentle restraint and 
accompanying autonomic phenomenon. Duration of antiepileptic 
treatment was decided based on neurological examination, cause of 
seizures and EEG. They also proposed that transient metabolic 
disturbances had no risk of  recurrence.
HALLIOGLU O et al,(59) studied 57 full term neonates with 
hypoxic insult admitted in NICU of tertiary care centre and analysed 
occurrence of seizures during first 24hrs and cranial USG in first five 
days of life in relation to mortality and neurological status at 2 yrs. In this 
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study of 57, 10 were lost to follow-up. 20 out of 47 had severe adverse 
outcome. Among predictors occurrence of seizures was poor predictor but 
cranial USG had 100% sensitivity and 55% specificity in predicting the 
outcome.
RONALD W. COHEN et al,(61) did a study from Department of 
Pediatrics, University of  California. Authors concluded that recent data 
derived from national collaborative perinatal project have been 
interpreted to show that 70% of  infants with neonatal seizures had 
normal outcome at 7yrs.
In a dissertation submitted by LUIS FERNANDO GARCIAS DA 
SILVA,(38) in PORTO ALEGRE, the incidence-density of  epilepsy in a 
population of  neonate inpatients with neonatal seizures was studied. The 
objectives were also to describe possible etiological factors related to 
neonatal seizures as well as neurophysiological abnormalities observed 
and to relate clinical and neurophysiological variables that could 
influence post-natal epilepsy development. It was a retrospective and 
prospective study. 127 babies were analysed for a period from January 
1987 to December 1997. All of them with clinically defined seizures, data 
of gestation, perinatal period and neonatal seizures were obtained 
retrospectively. Polygraphic recording  (PR) were analysed by experts in 
neonatal EEG tracings. Detailed questionnaires were prospectively 
collected for all infants with neonatal seizures, after informed consent. 
The incidence-density of epilepsy in 12 and 36 follow-up months was 
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22% and 28.3% respectively. Metabolic disturbances and asphyxia were 
the most frequent etiological factors observed. Polygraphic recordings 
were obtained in 110 newborns and considered normal in14 (12.7%) and 
abnormal in 96 (87.3%). Ictal discharge patterns were observed in 10 PR, 
abnormal paroxysmal patterns with or without ictal correlations in 74 PR 
and background abnormalities or EEG dysmaturity in 47PR. 
Anticonvulsants during the neonatal period and CNS infection are 
associated to post-natal epilepsy. Inter-ictal normal neurological 
examination and normal polygraphic recordings as well, were related to 
good outcome in this study. The conclusions of the study were that the 
Incidence Density of epilepsy in newborns with neonatal seizures was 
elevated. Metabolic disturbances and asphyxia were the most frequent 
etiological factors. Normal inter-ictal neurological examinations as well 
as PR have shown good outcome. CNS infection and the need for 
anticonvulsant therapy during neonatal period led to negative follow-up 
in this cohort.
SPITTLE et al,(55) in his meta-analysis demonstrated that early 
developmental interventions post-hospital discharge for preterm infants 
have a significant impact on cognitive development at infant and 
preschool age. However, there is currently little evidence of an effect of 
early developmental interventions post-hospital discharge on motor 
development at infant age. At school age there have only been three 
studies that investigated the long term effects of intervention on cognitive 
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outcome and two that investigated the effect on motor outcome, none of 
which demonstrated any substantial difference in long term outcomes. 
Interventions that focus on the parent-infant relationship, along with 
infant development, have the greatest impact on cognitive development in 
the short to medium term. The heterogeneity between early 
developmental intervention programs in regard to content, focus and 
intensity limit the conclusions that can be drawn from this review.
KAREEM I, et al,(39) in their study done at Nigeria  with 57 
infants with neonatal seizures over a 3yr period showed perinatal 
asphyxia and hypoglycaemia as the principal etiologic factors in 47 and 
19 per cent of the cases, respectively. Seizures were commoner in 
preterm, and among them outcome was also poorer. As regards 
etiological factors, outcome was poorest with perinatal asphyxia, with 
mean mental age of 72.5 (9.1) wks at a chronological age of 24months. 
Outcome in infants with seizures and coma was most favourably 
predicted by the absence of  abnormal neurological signs, and the way the 
infant was feeding at 7-10 days, all infants who were clinically and 
neurologically normal and taking more than half their estimated 
requirements by mouth at  7 days were not handicapped. Thus at the end 
the overall incidence of  neonatal seizures was 7.5/1000 live births and 
the mortality (19.3%) was closely related to the etiology. In view of the 
fact that the associated adverse perinatal events are largely preventable, 
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improved prenatal and perinatal health care delivery should lead to a 
decline in the frequency of neonatal seizures. 
ELENJICKAL MG. et al,(45) did a study in Pushpagiri Institute, 
Kerala. This study was done during April 2004 – July 2005. 55  high-risk 
neonates  were  followed up. Growth was compared with 2000 CDC 
charts and development assessment was done with Trivandrum 
Development Screening Chart and Denver Development Screening Test. 
Statistical analysis was done using Kappa and chi-square tests. A highly 
significant association was observed between the risk score and the 
severity or developmental delay. Kappa statistics revealed the 
Trivandrum Developmental Screening Chart (TDSC) and  Denver 
Development Screening Test (DDST) were in excellent agreement with 
each other, babies who received early intervention therapy came out with 
minimum impairment. Thus it was concluded that TDSC is equally good 
in detecting developmental delay compared to DDST and can be used as 
a rapid screening method by training paramedical staff.
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ETIOLOGICAL PROFILE IN VARIOUS 
STUDIES
Etiology
Levene 
et al
Goldberg et 
al
Watanabe 
et al
Bergman et 
al
HIE 53% 16% 53% 30%
Intracranial 
Hemarrhage
17%
Hypoglycaemi
a 
3% 2% 3% 5%
Hypocalcemia 22%
Malformations 8% 4%
Fifth day fits 52%
Meningitis 8% 3% 8% 7%
Idiopathic 8%
                                                                                        
GILMAN et al,(8) demonstrated seizure control with 
phenobabitone Alone in 77% of cases using rapid sequential method. 
With initial loading dose of 15-20 mg/kg and stepping 5-10mg/kg every 
30mts if  seizures were uncontrolled to a maximum of 40mg/kg this result 
was observed. 
TEMPLE et al ,(19) in his study with 14 neonates with seizures 
conducted a follow up study. At the end of 4yrs he found that 11 of  them 
had normal outcome. But when they were followed till adolescence, 
many of them had spelling and memory problems.
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BERGMAN et al(24) conducted a study in University of Pittsberg, 
Pennsylvania. They found that 53% of  HIE with or without  intracranial 
hemarrhage had severe to moderate neurological impairment.  Out of 18 
of them who had seizures for >4days, 16 were severely impaired. 18 
among 24 who required more than two antiepileptics were severely 
impaired. The unexpected late  seizure recurrence within this group was 
8% which led to the recommendation that anticonvulsant to be 
discontinued after two seizure free weeks in neonate.
A study carried out in  Leichester  University  Medical  School  by     M.I. LEVENE et al,(4) was 
with 61 neonates with gestational age of 35-42wks and time of convulsions of 2hrs-25days. 
The cause was evident in 92% of the infants. Commonest cause was perinatal asphyxia 
which accounted for 53%, 4% were due to infection, 5% due to metabolic disturbances 
and 3% was due to congenital malformations. Since 20% of cases was detected to have 
either intracranial hemarrhage or infarction or MCA territory by real time USG, routine 
imaging techniques was advised in all neonates with neonatal seizures.
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STUDY JUSTIFICATION
Seizures during neonatal period are relatively common, occurring 
in approximately 1% of all neonates. While in children seizures often 
occur in the absence of another neurological disorder, neonatal seizures 
frequently are a non specific sign of underlying disease. The neonatal 
seizures are considered  an acute manifestation of disturbance of neonatal 
brain. The technological advances in perinatal care have been promoting 
the survival of preterm and term newborns, morbidity however remains 
high determining serious neurological sequelae. Therefore, we aim at 
studying the outcome of neonatal seizures and prognostic factors 
influencing these outcome so that we can contribute to make a significant 
improvement in the management of neonatal seizures and long term 
outcome of these infants.
Different studies(1,2,4,6,37,44,48,60,61) done on neonatal seizures has given 
varied incidence with regard to etiology, mortality, seizure recurrence and 
neurodevelopment delay.  These variations in other studies may be due to 
different study population, ethnic variations, pattern of referral and 
available investigations. Hence we want to have our own experience of 
the etiology and outcome of neonatal seizures in this large referral 
hospital serving the population in this part of the country.
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STUDY OBJECTIVES
♦ To identify the etiological factors and to know clinical profile in 
neonates   with seizures who were admitted in medical newborn 
unit of Institute of Child Health and Hospital for Children.
♦ To determine the incidence of normal development after neonatal 
seizures.
♦ To determine other clinical outcomes like seizure recurrence, 
neurological sequelae and others.
♦ To determine prognostic factors of neonatal seizures.
♦ To identify the means and methods to prevent or modify these 
factors.
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SUBJECTS AND METHODS
STUDY PLACE 
This study was conducted in department of neonatology and 
neurology at Institute of Child Health and Hospital for Children, a tertiary 
care children hospital, Egmore, Chennai.
STUDY PERIOD : November 2006 to October 2008.
STUDY DESIGN : Prospective  Hospital  Based Study
STUDY POPULATION : Newborns with seizures admitted in medical newborn 
unit in Institute of Child Health and Hospital for Children in first six months of the 
study period Were enrolled in the study.
♦ INCLUSION CRITERIA
All term neonates with clinically diagnosed seizures by observation
♦ EXCLUSION CRITERIA
-Readmission
-Gestational age <37wks [ by modified Ballard scoring]
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SAMPLE SIZE
All children with above inclusion criteria who presented during 
first six months of study period.
STATISTICAL ANALYSIS
Proportions of various outcomes measured using Pearson Chi-
square test.
STUDY MANOEVURE
All term babies with seizures admitted in medical newborn ward of 
Institute of Child Health and Hospital for Children, who satisfied the 
inclusion Criteria during the first six months of study period, 1st 
November 2006 to 30th  April 2007 were enrolled in the study and 
followed up for a minimum period of one year ( 20% of  infants were 
followed up till one and half years).  A prior approval from the 
institutional ethical committee and informed consent from parents were 
obtained.
After enrolling, a detailed history and thorough clinical 
examination was done for all babies on admission and data collected were 
entered in the proforma. Every infant was followed up daily during 
hospital stay. The biochemical parameters including blood sugar by 
Glucose oxidase-peroxidase method, serum calcium using 
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O-cresophthalein complexon method, serum sodium and potassium using 
flame photometry and serum bicarbonate using titration method were 
done for all babies enrolled. Urine for metabolic screening which 
included Benedict’s test, Ferric chloride test, cetrimide test,  Dinitro 
phenyl hydrazine test and cyanidenitroprusside test was done. Blood 
culture and capillary blood gas analysis were done for all babies on the 
day of admission. Lumbar puncture with CSF analysis and 
Ultrasonography of cranium were done for all babies after hemodynamic 
stabilization. For babies in whom lumbar puncture could not be done 
before death, post- mortem lumbar puncture was done. Cerebro-spinal 
fluid was examined for cells, biochemical parameters including protein 
and sugar and its culture and sensitivity was also done. If any 
biochemical parameters were abnormal, they were repeated before 
discharge.
The babies were treated according to the underlying illness and 
were discharged. At the time of discharge, the babies were examined for 
presence of abnormal neurological sign. The weight, height, head 
circumference and chest circumference were noted for every baby. The 
parents were counseled regarding the outcome of neonatal seizures and 
the necessity of  follow-up. A CDC card with CDC register number was 
issued to every baby with details of follow-up dates.
The infants were followed up at 1,2,3,6,9 and 12 months of age at 
Child Development Clinic(CDC), which is a high-risk follow-up OP of 
Medical Newborn Unit. During each visit, babies were weighed first and 
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head circumference measured.  Growth of the baby was assessed with 
WHO chart.
History of seizure recurrence was enquired about and noted in 
follow-up proforma. In case of recurrence, antiepileptic  drug was advised 
and the drug was asked to be collected from Department of  Neurology. 
For those babies with seizure recurrence, Electroencephalography and CT 
Brain was done.
Detailed  neurological examination including Amiel Tison 
Angles(51)  were Done for all babies during each follow-up visits. A 
neonate is considered to be neurologically normal if there is no paucity of 
movements, cry, tone and neonatal reflexes are normal. If any 
abnormality detected, Early stimulation was taught to parents. 
Neurodevelopmental assessment was done at each visit using Trivandrum 
Development Screening Chart (Annexure IV).(14,45,52)  
Babies with neurodevelopment delay and neurological sequelae 
were treated With physiotherapy and were given multidisciplinary care.  
During each visit, parents were motivated for next visit and were 
advised regarding immunisation, weaning and nutrition of  their babies.
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Visual assessment(57) was done at three and six months by gross 
appearance of eyes, perception of light and following of  bright objects, 
visual fixation on coloured objects, red reflex by ophthalmoscopy, eye 
movement and  fundoscopy. Hearing assessment(57) was done at three and 
six months by behaviour observation audiometry or free field audiometry. 
BERA could not be done as the facilities were not available in our 
hospital. At the end of one year, various outcomes were analysed. 
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RESULTS AND ANALYSIS
For our study, the infants were enrolled from November 2006 to 
April 2007 and they were followed up for a minimum period of one year 
(to a maximum period of one and half years) from the date of enrollment. 
During  enrollment, total number of admissions in newborn unit was 
1913. Number of babies with seizures were 110, 5% of total newborn 
admissions. Among 110 babies, 11 babies were not enrolled because their 
parents were not willing. So remaining 99 neonates were enrolled in our 
study. Among the babies enrolled, 16(16%) died during hospital stay. 
Child Development Clinic (CDC) card and register number was issued to 
remaining 83 babies and were counseled for follow-up. However, during 
follow up, two babies died (both babies died due to sepsis, one of them at 
fifth month and the other at seventh month of follow up). At the end of 
study period, 81 babies had completed the follow up.
110 babies with neonatal seizures got admitted.
                                            11 drop-outs
                                  99 babies were enrolled.
                                        16 babies died
                      83 neonates were registered for follow up.
                                                 2 died during follow up
                            81 babies completed follow up.
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At the end of the study, the data was evaluated using Microsoft 
Excel Spreadsheet and the proportions of various outcomes were 
measured using Pearson Chi-square test. The data were analysed in the 
following headings:
I    Baseline data.
          II   Etiological factors.
III  Outcome measures.
IV  Analysis of risk factors for outcome.
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BASELINE DATA ANALYSIS 
All babies recruited for the study had gestational age >37wks. No 
preterm (by modified Ballard scoring) was included in the study.
CHARACTERS
NUMBER OF BABIES
(n=99)
n %
SEX Male 51 51
Female 48 49
NUTRITIONAL
STATUS
SGA 15 15
AGA 84 85
Thus among the study group, males and females were almost 
equal. Small for gestation age babies (with birth weight <2.5kg) were 
15(15%) of study population and among them, six of them were 
intrauterine growth retarded babies.  50% of newborns recruited for study 
was first born, 37% were second born and 12% of them were third born. 
The birth order of none of the babies were greater than three.
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HIGH RISK PREGNANCY
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babies
18% of the mothers had history of high risk pregnancy with 
Pregnancy Induced Hypertension predominating the list. Maternal deaths 
were observed among two babies (one of the maternal deaths in follow-
up babies was due to Post-partum hemorrhage and the other was an 
unmarried pregnancy where the cause of death was not related to 
pregnancy). Family history of seizures was present in 5% of cases and 
history of sibling death was present in 4% of the babies.
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          While analyzing the maternal data, 81% of them were in the age 
group of 20-30yrs. Only 5% of them were between 30-35yrs and 14% of 
them were teen age pregnancy. About 95% of the mothers had at least 
primary schooling done and only 30% of the babies were born  of 
consanguinous marriage. The awareness of importance of maternal and 
child health has increased which was shown in our study where 96% of 
the mothers had history of regular ante-natal checkups.
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PLACE OF DELIVERY
5% 6%
84%
5%
HOME PHC INSTITUTIONAL PRIVATE SECTOR
On analyzing the birth history of all babies registered, the 
proportion of  institutional deliveries has increased. Only 5% percent of 
the babies were delivered at home and one amongst all these home 
deliveries, was conducted by Untrained Dai. 84% of the babies were born 
under institutional care. 6% of babies born in primary health care were 
referred to our hospital for seizures.                   
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MODE OF DELIVERY
VAGINAL
FORCEPS
LSCS
073% of the babies were delivered by normal vaginal delivery while 
LSCS was the mode of delivery in 25% of the cases. 2% of babies 
however needed forceps delivery.
Perinatal factors were analysed and prolonged rupture of 
membranes for >24hrs were found in 2% of the cases and prolonged 
labor was found in 2% of the cases. History of meconium stained liquor 
was present in 11%, 1.2% had history of oligohydramnios and 2.5% had 
cephalo-pelvic disproportion. 12.5% of babies had history of cord around 
neck.
While analyzing the history for birth asphyxia, 35% had positive 
history. Among these babies, seven (9%) were severely asphyxiated and 
had history of bag and mask ventilation being used and they needed 
resuscitation for more than 20mts. 
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CO-MORBIDITIES
CO-
MORBIDITIES
NUMBER OF CASES
(n=99)
n %
ICTERUS 36 36.4
CHD 3 3
SHOCK 17 17.2
NOTE: CHD – Congenital Heart Disease.
In the post-natal period 36 babies had icterus but none of them had 
serum bilirubin greater than 15mg/dl. History of bad child rearing 
practices was present in 25% of cases and 3% babies had congenital heart 
diseases. Shock was a common co-morbidity associated with seizures 
especially in those babies with history of hypoxia. Babies who had severe 
shock, were the ones who succumbed to death in our study. Among the 
neonates who presented with shock, two of them (12%) survived as 
against 15 babies (88%) who died. Icterus and shock were the two co 
morbidities which had statistically significant association with neonatal 
seizures.
The day of onset of seizures, type of seizures, duration of seizures 
and the response of seizures to antiepileptic used were some of the 
important parameters considered to be important in a neonate presenting 
with neonatal seizures.
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Most of the seizures had their onset on one to three days. It 
accounted for 40% of the seizures, 29% of the seizures occurred on day 1 
of life and 21% had after third day. Only 10% of the babies presented 
with seizures after 14days.
Almost 77% of seizures (85% among the survived babies and 
37.5% among the babies who died) lasted only for less than five mts. 
19.5% had seizures lasting for 5-30mts and only 3.5% of the babies had 
seizures lasting for greater than 30mts. Ours being a tertiary care centre 
receiving referral cases, only 29% have been admitted with single episode 
seizures while 71% had multiple seizure episodes. However, 74% of 
seizures got controlled in one day, while 15% of seizures was brought 
under control in 1-3days. About 11% (7% among those who survived and 
25% among those who died ) of these babies had seizures controlled only 
after three days.
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TYPES OF SEIZURES(21)
15
34
22
7
1
20
SUBTLE
FOCAL CLONIC
MULTI FOCAL CLONIC
TONIC
GTCS
MIXED
 
NOTE: GTCS: Generalized Tonic Clonic Seizures
The type of seizures was clinically determined by observation. 
35% of the babies were found to have presented with focal clonic seizures 
while multifocal clonic seizures were observed in 22% of the cases. Only 
one case of Generalised Tonic Clonic seizures was observed in a case of 
hypoxia. Two cases had myoclonic seizures and 7% was observed to have 
tonic seizures. 15% neonates had subtle seizures, which included cycling, 
sucking, chewing, eyelid twitching, vacant stare, incessant cry, 
nystagmus and apnoea. Cycling, vacant stare and nystagmus were the 
commonest among them. Some of the babies (20%) presented with more 
than one seizure type. It was subtle seizures which occurred in 
combination with other seizure types. However, there were two babies 
who had myoclonic seizures with other seizure types. In our study, 
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myoclonic seizures never occurred isolated. Family history of seizures 
was present in 5% of the cases.
Among the babies recruited, 5% had microcephaly, abnormal 
neurological examination was present in 35% of the cases. The 
abnormality in the neurological examination included bilateral flaccid 
paralysis, bilateral spastic paralysis and depressed neonatal reflexes. 
However, none of them had unilateral flaccid weakness, unilateral spastic 
weakness or neurocutaneous markers which was looked for in all babies. 
Seven cases had congenital anomalies namely macule, polydactyly, and 
dysmorphic facies.
Seizure in the babies enrolled in our study was treated as per our 
hospital protocol. Nine babies did not require antiepileptics as their 
seizures got controlled with the treatment of their metabolic disturbances 
namely hypoglycemia or hypocalcemia. Phenobarbitone was the first line 
oantiepileptic drug used and it was observed that 72 (73%) babies got 
their seizure controlled with phenobarbitone. Remaining 18% of the 
babies needed more than one drug to control seizures.
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CORRELATION BETWEEN SEIZURE TYPES AND 
DAYS TO CONTROL SEIZURES
TYPE OF 
SEIZURES
(n=99)
DAYS TO CONTROL SEIZURES
<1day
(n=74)
1-3days
(n=15)
>3days
(n=10)
GTCS(1) 1 - -
Subtle (15) 14 - 1
Focal clonic(34) 29 5 -
MF clonic(22) 19 1 2
Tonic (7) 5 1 1
Mixed (20) 6 8 6
NOTE: GTCS: Generalised Tonic Clonic Seizures.
   MF  Clonic: Multifocal Clonic.
Focal clonic seizures were the commonest type of seizures and 
they were the seizures easy to control. 85% of focal clonic seizures got 
controlled in one day and none of them persisted after three days. 
Multifocal clonic and Subtle seizures had the similar trend in days 
taken to control them. However, one baby with subtle seizures and two 
with Multifocal clonic seizures had their seizures uncontrolled till three 
days. 30% of the Mixed seizures was difficult to control and took more 
than to three days to control and 40% of them needed more than one day 
to control. Among Tonic seizures, 71% of the babies had their seizure 
control within one day. Thus in general, most of the seizures got 
controlled within one day irrespective of seizure type. However, the 
babies presenting with Mixed seizure type required more days to control 
seizures
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INVESTIGATIONS
All the neonates included in the study underwent the panel of 
investigations and the results were:
INVESTIGATIONS RESULTS (n=99)
Normal Abnormal
Blood sugar 83 16
Serum calcium 84 15
Serum electrolytes 98 1
Urine for metabolic 
screening 
98 1
Blood culture 81 18
CSF analysis 94 5
USG Cranium 90 9
CBG analysis 97 2
          NOTE: CSF: Cerebro Spinal Fluid, USG: Ultrasonography
                      CBG: Capillary Blood Gas.
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NOTE: SUG: Blood Sugar, CAL: Serum Calcium, ELEC: Serum   
   Electrolytes, UMS:Urine for metabolic screening, NEC: Blood   
             culture.
While investigating the babies, the blood sugar value less than 
40mg/dl and total serum calcium less than 7mg/dl (ionized calcium 
<4mg/dl) were consideredhypoglycemia and hypocalcemia respectively. 
The analysis showed that 16% of babies had hypoglycemia and 15% had 
hypocalcemia. Only 1% had electrolyte abnormalities and that baby 
showed metabolic acidosis in capillary blood gas analysis. One neonate 
showed positivity in urine for metabolic screening  for Alkaptanuria 
which was not clinically related. Abnormal USG findings included 
resolving intra-ventricular hemorrhage, CNS Malformation namely 
periventricular leukomalacia, agenesis of corpus callosum (present in two 
cases) and features of HIE. The ultrasonography findings of HIE(56) 
included cerebral edema, loss of gyral and sulcal pattern and parenchymal 
bleeds. Extradural fluid with dilated ventricles with turbid fluid was 
present in one baby. One of the newborns also had echogenic region in 
left frontal region in ultrasonography. Thus 9% of the babies had 
abnormal Ultrasound cranium. 18%  had pathogenic growth in their blood 
culture and 5% had abnormal Cerebrospinal fluid analysis with increased 
protein andorganism grown in culture of CSF.
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ETIOLOGY
Etiology, being the powerful prognostic indicator was analysed in 
our study.
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On analysis of the etiological profile of the babies in our study, the 
bulk of the cases were due to hypoxic insult, infection and metabolic 
causes. Among 99 newborns enrolled, hypoxia(2) was found to cause 
seizure in 29 (30%) babies, septicemia in 19 (19%) and hypoglycemia(16) 
in 13 (13%) babies. Four  babies had meningitis and ten babies had 
seizures because of hypocalcemia.
Benign neonatal seizures was diagnosed in one child and three 
babies had CNS malformations. Intra-ventricular hemorrhage and Inborn 
Error of Metabolism was found to be the etiology in 2% of the neonates 
included in the study. However the cause of the seizures could not be 
found in 16 babies(16%).
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CORRELATION BETWEEN DIAGNOSIS AND 
TYPE OF SEIZURES
          The etiology of the seizures and its association with type of 
seizures were analysed. The results are as follows:
DIAGNOSIS
(n=99)
TYPES OF SEIZURES
Subtle
(n=15)
Tonic
(n=7)
MFC
(n=22)
F 
Clonic
(n=34)
GTCS 
(n=1)
Mixed
(n=20)
Septicemia(19) 2 1 6 7 3
Meningitis(4) - - 1 2 1
Hypocalcemia(10) 2 2 1 3 2
Hypoglycemia(13) 7 1 3 2 -
Hypoxia(29) 1 2 3 12 1 10
Idiopathic(16) 2 1 4 6 3
BNS(1)               1 - - - -
Malformations(3) 1 1 1
IVH(2) 1 1 -
IEM(2) 2 -
NOTE: MFC: Multifocal Clonic, F Clonic: Focal Clonic, GTCS: 
Generalised Tonic Clonic seizures, IVH: Intraventricular hemorrhage, 
IEM: Inborn Error of Metabolism, BNS: Benign Neonatal Seizures.
In babies with septicemia and meningitis clonic (both focal and 
multifocal) seizures were common. Among metabolic seizures, 
hypocalcemia presented as clonic seizures while in hypoglycemia, subtle 
seizures were common.  Two cases of hypocalcemia had mixed seizures 
while none of the hypoglycemic seizures were of mixed type.  Most of 
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the clonic seizures were of hypoxic etiology while tonic seizures were 
common in hypoxia and hypocalcemia. Benign neonatal seizures 
presented as subtle seizures.  Generalized tonic clonic seizures occurred 
in one neonate who had hypoxic etiology. Clonic seizure was the type of 
seizure in Intraventricular hemorrhage and Inborn Errors of Metabolism 
and also contributed to the bulk of cases in whom etiology was not 
detectable. Mixed seizures were also observed among 20% of newborns. 
Hypoxia was the common etiology associated with mixed seizures. 
However, mixed seizures were also observed in septicemia, 
hypocalcemia, malformation and idiopathic seizures.
CORRELATION BETWEEN DIAGNOSIS AND DAY 
OF ONSET OF  SEIZURES
DIAGNOSIS
(n=99)
DAY OF ONSET OF SEIZURES
<1day
(n=29)
1-3days
(n=40)
4-14days
(n=20)
>14days
(n=10)
Septicemia(19) 1 7 6 5
Meningitis(4) - 1 3 -
Hypoglycemia(13
)
2 11 - -
Hypocalcemia(10) 3 4 2 1
Hypoxia(29) 18 7 3 1
Idiopathic(16) 1 8 4 3
BNS(1) - - 1 -
Malformations(3) 2 1 - -
IEM(2) 1 1 - -
IVH(2) 1 - 1 -
   NOTE: BNS: Benign Neonatal Seizures, IEM: Inborn Error of 
Metabolism, IVH :  Intraventricular hemorrhage.
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In the babies with hypoxia, 25(86%) babies had their seizure onset 
within three days [18 (62%) babies within one day]. Late onset seizures 
were more common in babies with Septicemia. Among hypocalcemia, 
7(70%) babies had early onset hypocalcemia and remaining 30% had late 
onset hypocalcemia. All hypoglycemic seizures occurred within three 
days. About 85% of babies with hypoglycemia had seizures between 1-
3days. Congenital malformations of brain presented with seizures within 
three days, about 66% within one day and similar trend was noted in 
Inborn Errors of Metabolism. Most of the late onset seizures were due to 
septicemia or idiopathic,
CORRELATION BETWEEN DIAGNOSIS AND 
DURATION OF SEIZURE CONTROL
   DIAGNOSIS (n=99) DURATION OF SEIZURE CONTROL
< 1day 
(n=74)
1-3 days 
(n=15)
>3 days 
(n=10)
Septicemia(19) 14 4 1
Meningitis(4) 4 - -
Hypocalcemia(10) 8 2 -
Hypoglycemia(13) 10 2 1
Hypoxia(29) 23 4 2
Idiopathic(16) 13 2 1
Malformations(3) - 1 2
IVH(2) 1 - 1
IEM(2) - - 2
BNS(1) 1 -             -
NOTE: IVH: Intraventricular hemorrhage, IEM: Inborn Error of 
Metabolism,  BNS: Benign Neonatal Seizures.
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              Irrespective of etiology, 75% of infant had seizures controlled 
within one day. Only 10% of the seizures needed >3days for control. 
Seizures which took greater than three days to get controlled were caused 
by hypoglycemia, hypoxia, Inborn Error of Metabolism and 
Malformations of brain, with CNS Malformation topping the list. About 
66%  of babies with CNS Malformation had prolonged seizures.
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OUTCOME MEASURES
Among 110 cases recruited, 11 cases dropped out as the parents 
were not willing. Thus 99 cases were enrolled. 16 (16%) cases among 
them succumbed to death during neonatal period.
RISK FACTORS FOR MORTALITY
          RISK 
FACTORS
TOTAL 
(n=99)
NUMBER OF 
DEATHS
(n=16)
p-value
n %
Nutritional 
status
SGA 15 1 6.6 0.227
AGA 84 15 17.8
H/oBirth 
asphyxia
PRESENT 34 9 26.4 0.050
ABSENT 65 7 10.7
NOTE: SGA: Small for Gestation age, 
  AGA: Appropriate for gestation age.
In the neonates with history of birth asphyxiaand seizures, 26.4% 
died as compared to 10.7% among those who did not have history of birth 
asphyxia which also showed  statistically  significant association. 
However SGA did not show increased incidence of death. Thus 
nutritional status among babies with neonatal seizures is not a risk factor.
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          RISK FACTORS
TOTAL 
(n=99)
      NUMBER OF
DEATHS (n=16) p-value
n %
Day of 
onset of 
seizures
<1day 29 8 27.5
0.1511-3days 40 4 10
4-14days 20 2 10
>14days 10 2 20
Type of 
seizures
Subtle 15 3 20
0.092
Focal clonic 34         3      8.8
MF clonic 22 2 9
GTCS 1 - -
Tonic 7 3 43
Mixed 20 5 25
Days to 
control 
seizures
<1day 74 9 12
        0.0831-3days 15 3 20
>3days 10 4 40
Number 
of drugs 
used
Phenobarbitone 72 9 12.5
<0.001**
+ phenytoin 5 - -
+ midazolam 11 7 63.6
Others 2 - -
No drugs used 9 - -
 NOTE: ** denotes significant at 1% level
    *  denotes significant at 5% level.
       Seizures and its character play a major role in determining the 
outcome in neonatal seizures. In our study, out of 10 babies whose 
seizure onset was greater than 14 days, 20% of them died as compared to 
27.5% among those who had their onset within one day. The mortality 
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was lowest (10%) when seizure started between 1-14days. Both very 
early onset (<1day) and very late onset (>14days) were associated with 
poor prognosis. Even though subtle seizures were the commonest, it was 
the tonic seizure which had highest correlation with mortality. About 
43%  of neonates with tonic seizures died while 8.8% died among babies 
with focal clonic seizures. Greater the days taken to control seizures 
higher was the mortality though it did not reach statistical significance. 
Among 10 newborns who had prolonged seizures, 40% met with death 
whereas among 72 babies who got their seizure controlled in one day 
only 12% died. Among our study population, among those who 
responded to phenobarbitone therapy alone, 12.5%  died. But others 
needed multiple drugs and 63.6% of them succumbed to death. Thus 
early and late onset seizures, seizure type, prolonged seizures and 
seizures which needed multiple drugs had highest risk of mortality. 
However, when analysed, number of drugs used was the only parameter 
which showed statistically significant association with mortality. 
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       RISK 
FACTORS
TOTAL 
(n=99)
NUMBER OF 
DEATHS(n=16) p-value
n %
Co-morbidities 
(Shock)
Present 17 15 88.2
     <0.001**Absent 82 1 1.2
Neurological 
examination
Normal 65 2 3      
     <0.001**Abnormal 34 14 41.1
Both comorbidities and neurological examination were found to 
have significant role in determining outcome especially mortality. Shock, 
which was the major comorbidity seen in neonatal seizures, was 
associated with a mortality of 88.2% while only 1.2% of the  babies who 
did not have shock died. Neurological examination which is the simple 
tool to assess, on analysis showed that 41.1% of  neonates with abnormal 
neurological examination died while only 3% of babies with normal 
neurological examination died. Both had significant p-value.
As 16 babies died during neonatal period, remaining 83 were 
followed up. However during follow-up, 2 babies died. Thus 81 babies 
completed follow-up for one year period and their clinical outcome was 
analysed at the end. Thus at the end of one year, 64% had normal 
outcome(1). Among the remaining, seizure recurrence and neurological 
sequelae were two major outcomes measured which was present in 16% 
and 20% of  infants respectively. Other adverse outcomes noted were 
developmental delay in 11%, microcephaly in 5%, isolated speech delay 
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in 3.5% and failure to thrive in 2% of infants. Vision and hearing 
assessment in all babies did not show any abnormality. The risk factor 
assessment for two major outcomes, seizure recurrence and neurological 
sequelae is as follows.
RISK FOR SEIZURE RECURRENCE
RISK FACTORS
TOTAL
(n=81)
NUMBER OF
SEIZURE
RECURRENCE
(n=13)
p-value
n %
Nutritional 
status
SGA
AGA
15
66
2
11
13
16
0.751
History of 
birth asphyxia
Present
Absent
25
56
5
8
20
14
0.518
NOTE: SGA: Small for gestation age, 
  AGA: Appropriate for gestation age.
While analyzing the role of nutritional status and birth asphyxia as 
a risk factor for seizure recurrence, both did not show any significant 
correlation. 13% of SGA babies had seizure recurrence as compared to 
16% among AGA babies and 20% of babies with asphyxia had 
recurrence while 14% of babies who did not have asphyxia had seizure 
recurrence.
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RISK FACTORS
TOTAL
(n=81)
NUMBER OF
SEIZURE
RECURRENCE
(n=13)
p-value
n %
Day of onset 
of seizures
     <1day
    1-4days
    5-14days
    >14days
19
36
18
8
8
3
1
1
42
8
5
12
0.005**
Days taken to
Control 
seizures
    <1day
    1-3days
     >3days
63
12
6
8
3
2
12.6
25
33.3
0.251
Family H/O 
seizures
    Present
    Absent
5
76
1
12
20
15.7
0.804
Type 
of seizures
    Subtle    
    F Clonic 
    Tonic
    MF clonic
   Mixed 
12
30
4
20
15
1
3
2
4
3
8
10
50
20
20
0.533
          Among the babies who had the seizures onset on day1, 42%  had 
seizure recurrence while those with seizure onset after 14 days 12% had 
seizure recurrence. Longer the days taken to control seizures, more was 
the seizure recurrence. 12.6% was the recurrence rate among the babies 
who had seizure controlled within one day. 33.3% babies were observed 
to have seizure recurrence among those whose seizures were not 
controlled even after three days. Among the babies who had their seizure 
controlled less than three days but longer than one day, 25% had seizure 
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recurrence. While correlating with family history of seizures, it was 
observed that 20% of those with positive family history had seizure 
recurrence after neonatal period while it was seen in 15.7% cases without 
family history. Seizure recurrence was also influenced by type of 
seizures. Tonic seizures topped the list of type of seizures with seizure 
recurrence. 50%  with tonic seizures had seizures recurrence and 20% of 
mixed and multifocal clonic seizures had seizure recurrence. While 
analyzing babies who presented with subtle and focal clonic seizures, 
only 8% and 10% of babies respectively had seizure recurrence.
Thus among the characteristics of seizures, early onset seizures, 
refractoriness of the seizure and the type of seizure were more 
influencing on the outcome, especially seizure recurrence. Among these 
characteristics, Day of onset of seizures had a significant p-value.
       RISK FACTORS
TOTAL
(n=81)
NUMBER OF 
SEIZURE
RECURRENCE 
(n=13)
p-value
n %
Microcephaly Present
Absent 
4
77
2
11
50
14.2
0.058
Neurological
Examination
Normal 
Abnormal
61
20
10
3
16
15
0.883
USG 
Cranium
Normal 
Abnormal 
72
9
8
5
11
55.5
<0.001**
NOTE: USG: Ultrasonography.
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Among babies with microcephaly and neonatal seizures, 50% had 
seizure recurrence on follow-up. While neurological examination did not 
seem to predict the seizure recurrence, abnormality in ultrasonography 
was a  good predictor. 15% of babies with abnormal neurological 
examination had seizure recurrence as compared to 16% in those whose 
neurological examination was normal. 55.5% of the newborn with 
Ultrasound abnormality had seizure recurrence while among those with 
normal Ultrasound only 11%  had seizure recurrence. Significant p-value 
is obtained only for abnormal ultrasound.
RISK FACTORS FOR NEUROLOGICAL SEQUELAE
RISK FACTORS TOTAL 
(n=81)
NUMBER OF 
CASES WITH NS 
(n=17)
p-value
n %
Nutritional 
status
SGA 
AGA
15
66
4
13
26
20
0.549
History of 
birth asphyxia
Present
Absent
25
56
9
8
36
14
0.027*
H/O prolonged 
labor
Present
Absent
2
79
1
16
50
20
0.307
NOTE: NS: Neurological Sequelae, SGA: Small for gestation age, 
 AGA: Appropriate for gestation age.
36% of the babies with birth asphyxia developed neurological 
sequelae and 50% of babies with history of prolonged labor had 
neurological sequelae at the end of one year follow-up. Birth asphyxia 
has significant association with neurological sequelae (p-value <0.05). 
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However SGA babies were not found to have a significant role as 
evidenced by 26% of them developing neurological sequelae as compared 
to 20% among AGA babies.
RISK FACTORS TOTAL
 (n=81)
NUMBER OF 
CASES WITH NS
(n=17)
p-value
n %
Day of onset 
of seizures
<1day
1-3days
4-14days
>14days
19
36
18
8
10
5
1
1
52
14
5
12
0.001**
Type of 
seizures
Subtle
Foc. clonic
MF clonic
Tonic 
Mixed
12
30
20
4
15
1
6
2
3
5
8
20
10         
75
33
0.21
Days taken 
to control 
seizures
<1day
1-3days
>3days
63
12
6
9
6
2
14
50
33.3
0.015*
NOTE: NS: Neurological Sequelae, Foc.: Focal, MF: Multifocal.
Among babies who had their seizure onset within one day, 52% 
had neurological sequelae while among those having onset after 14days 
only 12%  had abnormal neurological outcome. Similar to the seizure 
recurrence, mixed  and tonic seizures had increased incidence of 
neurological sequelae. 33% of babies with mixed seizures and 75% of 
tonic seizures had abnormal neurological outcome. 8% of neonates with 
subtle seizures and 20% of them with focal clonic seizures had 
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neurological sequelae. Prolonged seizures had more incidence of 
neurological sequelae. Thus early onset seizures, mixed seizures, tonic 
seizures and seizures resistant to treatment were commonly associated 
with neurological sequelae and statistically significant p-value was 
obtained for Day of onset of seizures and Days taken to control them. 
RISK FACTORS
TOTAL
(n=81)
NUMBER OF 
CASES WITH NS
(n=17)
p-value
n %
Neurological 
examination
Normal
Abnormal
61
20
10
7
16
35
0.076
USG cranium Normal
Abnormal
72
9
11
6
15
66.6
<0.001**
Microcephaly Present
Absent
4
77
2
15
50
19
0.144
NOTE: NS: Neurological Sequelae, USG: Ultrasonography.
When the baby had abnormal neurological examination during neonatal 
period, abnormal ultrasonography or microcephaly then the risk of that 
newborn going for neurological sequelae is more. Among our study population, 
35% of those with abnormal neurological examination as against 16% babies 
with normal neurological examination, 50% of  those with microcephaly as 
against 15% babies with normal head circumference and 66.6% with abnormal 
ultrasonography compared to 19% among babies with normal ultrasound 
cranium had abnormal
neurological outcome at the end of one year. However, significant p-value was 
obtained only for abnormal ultrasonography cranium. 
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ETIOLOGY AND OUTCOME
Etiology
Total
(n=99)
Number Of 
Seizure 
Recurrence 
(n=13) n(%)
Number Of 
Neurological 
Sequelae
(n=17) n(%)
Number Of 
Death 
(n=16) 
n(%)
Septicemia 19 2(10.5) - 4(21)
Meningitis 4 - - 1(25)
Hypocalcemia 10 - 2(20) 2(20)
Hypoglycemia 13 - 2(15) -
Hypoxia 29 5(17.2) 8(27.5) 7(24)
Idiopathic 16 3(18.75) 1(6) -
BNS 1 - - -
Malformations 3 1(33.3) 3(100) -
IVH 2 1(50) 1(50) 1(50)
IEM 2 1(50) - 1(50)
NOTE: BNS: Benign neonatal seizures, IVH: Intraventricular 
hemorrhage, IEM: Inborn Error of Metabolism.
          Among the study group, 10.5% of the babies with septicemia had 
seizure recurrence and 21% of them died. However none of the babies 
developed neurological sequelae. Among those who had meningitis, 25% 
babies died, but none of the survived babies developed any abnormal 
outcome during the study period. Metabolic disturbances like 
hypocalcemia and hypoglycemia were associated with neurological 
sequelae in 20% and 15% respectively and both of them were not 
associated with seizure recurrence. However, in babies with seizures and 
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hypocalcemia,  20% died. Hypoxia was the only etiology which was 
observed to cause all abnormal neurological outcome. 17.2% had seizure 
recurrence, 27.5% had neurological sequelae and 24% of babies 
succumbed to death among the neonates who had hypoxic insult. None of 
the newborns with unknown etiology died, there were less percentage of 
babies who developed seizures on follow-up and 6% ended up with 
neurological sequelae at the end of one year. Benign neonatal seizures 
was the only etiology which did not have any abnormal outcome, though 
there was only one case. Among the babies who had CNS malformation, 
none died but about 30% had seizure recurrence and 100% had 
neurological sequelae. While analyzing the babies with Intraventricular 
hemorrhage, seizure recurrence and neurological sequelae was observed 
in 50% of the cases while 50% died. Among the neonates who were 
diagnosed to have Inborn Error of Metabolism, 50% died and 50% had 
seizure recurrence but neurological sequelae was not observed in any of 
those babies. Hypoxia, malformations, Intraventricular hemorrhage and 
Inborn errors of metabolism were the most common etiologies which 
were associated with abnormal neurological outcome. However, etiology 
had a significant association (p-value=0.002) with neurological sequelae 
while not with seizure recurrence or death. But when analysed using 
Mantel-Haenszel test for linear association, both neurological sequelae 
and seizure recurrence had significant p-value of 0.009 and 0.019 
respectively.
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DISCUSSION
Seizures are relatively common in neonatal period and there have 
been numerous studies looking at clinical profile, outcome and prognosis 
of patients with neonatal seizures. Hence to have our own experience of 
the etiology and outcome of neonatal seizures in this large referral 
hospital this study was undertaken.
          Our statistics of the neonates admitted with seizures in the 
medical newborn ward of our institute in the recruitment period of six 
months is as follows:
CHARACTERS TOTAL NUMBER
Total admission in MNB ward 1913
Number of cases of neonatal 
seizures
110(5.7%)
Total deaths in MNB ward 350(18.2%)
No. of deaths among neonatal 
seizures
16(4.5% of ND)
 NOTE: MNB: Medical New Born, ND: Neonatal Deaths.
 We were not able to estimate the incidence of neonatal seizures in 
our study, because ours being a referral hospital without intramural 
facilities, many subtle seizures and single episode seizures which are 
usually not referred would be missed. Thus we would be underestimating 
the incidence of neonatal seizures.
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While analyzing baseline characteristics, the incidence among male 
and female babies were almost equal. With improvement in perinatology, 
the incidence of teen-age pregnancy has decreased accounting for only 
14%, in our study and the unbooked pregnancy was only 5%. Institutional 
deliveries have increased and only 5% had history of home delivery. 5% 
of the babies presented with microcephaly and 35% had abnormal 
neurological examination in form of bilateral spastic or flaccid weakness 
or depressed neonatal reflexes. Shock was present in 17% of the babies 
and it was associated with mortality in 88% of the cases.
69% of the seizures had their onset in first three days of life, 
however there were 10% of them who had seizure onset after 14 days. 
The most common seizure type was Focal and Multifocal clonic and 
Subtle seizures. GTCS was observed only in one case. Other seizure type 
observed in our study were myoclonic and tonic seizures which were rare 
but were difficult seizures to control. 20% of babies had mixed type of 
seizures. Babies with subtle seizures in our study had motor automatism 
including ocular, oro-bucco-lingual, progressive movements and 
autonomic features. However cycling movement, vacant stare and 
nystagmus predominated. Motor automatism observed in our study was 
similar to those monitored by KELLAWAY and MIZRALI in their 
study and also showed that focal clonic convulsions were the 
predominant seizure type.
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Inspite of 71% of babies having multiple episodes of seizures, 77% 
of them lasted only for <5mts and 74% got controlled in one day. 
Seizures which were prolonged and refractory to treatment were present 
in less than 10% of the babies and 18% required more than one drugs to 
control seizures. Phenobarbitone(41) was the first line antiepileptic used 
which achieved seizure control in 73% of the babies. This result is similar 
to one reported by GILMAN et al where 77% of babies had seizure 
control with phenobarbitone.
ETIOLOGY OF SEIZURES
A specific etiology for neonatal seizures can usually be identified 
in the majority of cases. In our study also, the cause of neonatal seizures 
was not detectable only in 16% of the babies. Hypoxia(2) contributed to 
the bulk of cases. About 30% of the babies had HIE ( 43.75% among 
babies who died and 25% among who survived). Infection was the next 
common etiology. Metabolic disturbance like hypoglycemia and 
hypocalcemia and inborn errors of metabolism contributed to neonatal 
seizures in 13%, 10% and 2% of the cases respectively. CNS 
malformation and Intraventricular hemorrhage were also diagnosed in 
<5% of the cases.
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In the study of  IYPE et al, HIE, hypoglycemia and meningitis 
contributed to the bulk of cases. TEKGUL et al, in their study, found that 
etiology of neonatal seizures was identifiable in 77% of the cases and 
global or focal cerebral hypoxia-ischemia and intracranial hemorrhage 
were the commonest etiologies. LEVENE et al found that 53% of the 
neonatal seizures was due to HIE, 4%  due to infection, metabolic and 
CNS malformation. 75% of the babies with neonatal seizures had their 
etiology identified in a study undertaken by ARTHUR L. ROSE et al 
and 25% were idiopathic. In the study of KAREEM et al, perinatal 
hypoxia and hypoglycemia were found to be the principle etiologic 
factors accounting for 47% and 19% of cases respectively. 
Our study also showed that etiology was identifiable in 84% of the 
babies and etiological profile was similar to all other studies with hypoxia 
predominating the list followed by Infection and Metabolic disturbances.
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OUTCOME MEASURES
          Neonatal seizures in many studies, have been shown to have long 
term detrimental effects on behaviour, seizure susceptibility and brain 
development. On evaluating, the long term outcome in our study 
population, 16% succumbed to death during the neonatal period. Among 
the remaining babies who were followed up, 64% had normal outcome(1). 
17(20%) of the babies had neurological sequelae and 13 (16%) had 
seizure recurrence. The neurodevelopmental outcome in our study was 
monitored by Trivandrum Development Screening Chart(TDSC)(14,45). 
TDSC is a simple developmental test designed and validated for children 
below two years of age. There are 17 test items in the chart chosen from 
the norms given in Bayley Scales of Infant Development. It does not 
require any special kit and takes only 5-7mts.
          In the study of IYPE et al, 68% had normal outcome, 32% had 
abnormal neurological outcome and 7% had seizure recurrence. The 
follow-up period in this study was four months.
          In a Canadian study, at 10yrs 35% had normal outcome and 34% 
had postneonatal epilepsy. The same cohort when followed up till end of 
decade showed that only 12% had normal outcome and seizure recurrence 
was present in 48% babies. Sample size was not mentioned in this study. 
It was concluded in this study that , short term follow-up usually shows 
better outcome. Similarly in TEMPLE et al study of 4yrs follow-up 11 
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out of 14 had normal outcome. However the same children followed up 
till adolescence showed spelling and memory problems. In the study of 
ARTHUR et al, 50% had normal outcome, 30% had neurological deficits 
and 20% died. 
          7% mortality and 28% poor neurological outcome were reported in 
the study by TEKGUL et al with a follow-up period of 12-18months. 
GABRIEL et al, in his study on neonatal seizures, followed up 82 babies 
and his results showed 45%  normal outcome, 16% death and 39% 
impairment. HARVARD study showed 70%  normal outcome, 13% 
cerebral palsy and 20% seizure recurrence. RONALD et al showed in his 
study that 70% had normal outcome at 7yrs following neonatal seizures 
as compared to 64% in our study.
          Except for Canadian study which showed 34% seizure recurrence, 
the results of our study were almost similar  to all other studies. Follow-
up for longer period may have shown similar results to the Canadian 
study.
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ANALYSIS OF RISK FACTORS FOR ADVERSE 
OUTCOME 
Among the various risk factors analysed babies with early onset seizures 
(especially within one day) and seizures refractory to treatment (seizures which 
required more than one drug or took more than three days to get controlled) had 
increased incidence of mortality, seizure recurrence and neurological sequelae. 
Resistant seizures notably had increased risk of mortality.  Small for gestational age 
babies had the same risk for the bad outcome as Appropriate for gestation age babies 
and the same results were obtained in the study of IYPE et al. The babies with birth 
asphyxia showed increased incidence of abnormal outcome. While evaluating type of 
seizures, tonic seizures followed by mixed seizures showed high incidence of 
abnormal outcome. During discharge, if the neonate was found to have abnormal 
neurological examination, on follow-up, the incidence of neurological sequelae was 
high (35% as compared to 16% in normal child). The mortality rate among them was 
50%, however seizure recurrence was comparable to those who had normal 
neurological examination. The presence of co-morbidities especially shock 
determined the immediate outcome in neonatal seizures. About 88.2% of babies with 
shock died during neonatal period while the incidence of death among those who did 
not have shock was 1.2%. All babies recruited for study had ultrasonography cranium 
done. At the end of study, it was found that among babies with abnormal USG 55% 
had seizure recurrence and 66% of them developed neurological sequelae.
Etiological factors has been determined to be the most critical 
factor in determining outcome in many studies. In our study, the same 
was proved. 100% of infants with Malformations and 50% of them with 
Intraventricular hemorrhage had abnormal neurological outcome while 
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50% of Intraventricular hemorrhage and Inborn Error of Metabolism had 
seizure recurrence. Beside these hypoxia-ischaemia was found to be an 
important etiology which showed increased incidence of seizure 
recurrence and neurological sequelae. Hypoxia was the commonest 
etiology associated with mortality. Benign neonatal seizures and transient 
metabolic disturbances had normal outcome. The risk of abnormal 
neurological sequelae (6%) and seizure recurrence (18.75%) was much 
lower when the etiology of neonatal seizures could not be identified.
          Thus early onset seizures, seizures difficult to treat, abnormal 
neurological examination, abnormal ultrasonography, presence of co-
morbidities like shock, mixed and tonic seizures and identifiable etiology 
were found to be major risk factors determining the outcome in infants 
with neonatal seizures.
         IYPE et al, could not identify any risk factors for seizure 
recurrence. They also proposed that hypocalcemia was significantly 
associated with mortality. In HARVARD study, Low Birth Weight, early 
onset sepsis and prolonged seizures were identified as prognostic factors. 
KELLAWAY and MIZRAHI proposed that 100% of cerebral 
dysgenesis and 30% Hypoxic Ischaemic Encephalopathy  had risk of 
recurrence of seizure and none of transient metabolic disturbances had the 
risk of recurrence which was similar to our study.
          TEKGUL et al, in their study showed a strong association between 
seizure etiology and outcome especially with cerebral dysgenesis, global 
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hypoxia-ischaemia and poor outcome. While analyzing neurological 
examination, they proposed that normal neurological findings had 
favourable outcome however abnormal neurological examination lacked 
specificity. The variables associated with poor prognosis, as determined 
by GABRIEL et al in their study were severe hypoxic encephalopathy, 
cerebral dysgenesis, complicated Intraventricular hemorrhage  and the 
need for multiple drugs. They also showed that  pure clonic seizures had 
favourable outcome whereas myoclonic seizures had increased mortality. 
HALLIOGLU et al in their study showed that cranial USG has 100% 
sensitivity and 55% specificity in predicting outcome. 
          GABRIEL et al, TEKGUL et al, KELLAWAY and MIZRAHI, 
ARTHUR et al, Canadian study and IYPE et al proved in their studies 
that  Electroencephalography was the major determinant of long term 
prognosis. However, due to technical difficulties, we were not able to do 
Electroencephalography  in our study. Other risk factors and their role in 
predicting long term outcome as determined in our study was similar to 
other studies.
            During the follow-up period, if any baby was found to have any 
developmental delay, the parents were taught about Early Infant 
Stimulation. Early Infant Stimulation(52,53,54,55) is now a well established 
strategy for preventing or reducing disability resulting from early CNS 
damage. When there is neuronal damage during prenatal period and 
infancy, activating of the spared synapses and relocation of the activity of 
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the damaged neurons is possible if spared synapses could be saved by 
stimulation. Infant Stimulation can be provided by structuring the 
environment to facilitate sensory, motor stimulation and also through 
direct responsive interaction with the mother or the caregiver. Marked 
improvement in the performance, hearing and speech subscales as well as 
development quotient have been observed in one Jamaican study. In a 
meta analysis done by SPITTLE AT et al, the crucial importance of 
stimulation during the early periods of development is emphasised as the 
motor, social and cognitive skills developed during this period have 
strong implication for future life-long development.
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SUMMARY AND CONCLUSIONS
♦ Among the neonatal admissions, 5% of newborn had seizures in 
this extramural newborn ward.
♦ Sex of the baby does not have significant association with neonatal 
seizures.(31)
♦ Focal and multifocal clonic were the commonest type of seizures.
(21)
♦ The obvious cause for seizures was not detectable in 16% of the 
neonates and probably they were idiopathic.(1,2,6)                         
♦ Hypoxia(2) was the most common etiology and was found in 30% of 
the babies. 
♦ Seizure control was achieved in one day in 74% of the babies.
♦ Treatment includes specific therapy for cause and antiepileptic 
drugs. The goals of treatment need to be tailored to specific 
situation.
♦ Phenobarbitone was used as first line antiepileptic drug and it 
achieved seizure control in 73% of the neonates.(28,41)
♦ Among the babies with neonatal seizures, 16% died. Birth 
asphyxia, seizures   controlled with multiple drugs, presence of co-
morbidities especially shock and abnormal neurological 
examination were the important risk factors for mortality.
♦ Among the babies followed up, 64%(1)  had normal outcome. So 
aggressive treatment of seizures is suggested. 
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♦ Seizure recurrence was observed in 13 (16%) babies at the end of 
one year follow-up. Early onset seizures(21)and abnormal 
ultrasonography of cranium were the risk factors identified for 
seizure receurrence in neonates with seizures.
♦ Seventeen (20%) babies with neonatal seizures had neurological 
sequelae on   follow-up of one year. The risk factors for abnormal 
neurological outcome were  birth asphyxia, Early onset seizures, 
Seizures which took more days to control and Abnormal 
ultrasonography of cranium.
♦ Prognosis following neonatal seizures is extremely variable and 
depends mostly on the underlying etiology of seizures(1,2,6,63). 
Etiology of seizures has significant   association with neurological 
sequelae than with seizure recurrence or death.
♦ In general, long term prognostication of babies with neonatal 
seizures is guarded in early onset seizures, recurrent seizures, 
refractory seizures, mixed and tonic  type seizures(21) , babies with 
abnormal neurological examination and those with  abnormal 
ultrasonography.
♦ Neurological examination is the tool not requiring sophisticated 
technology and  is ideally suited for outcome prediction in Indian 
setting(44) . If any abnormality detected, Early Infant Stimulation 
can be advised, which has shown promising role in improving 
neurological status of high-risk babies in many 
studies(52,53,54,55).  
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